Fast-food chain McDonald’s, an economic indicator because of its mammoth global presence, posted its worst earnings report since 2020.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
“Any potential cost savings based off a vehicle’s lower-than-average carbon footprint could influence more price-conscious consumers.”
Robert “Kelly” Ortberg, an industry veteran, will take over as Boeing’s CEO on Aug. 8, inheriting its financial woes.
Uber announced a new partnership with BYD to get 100,000 of its drivers into the company’s electric vehicles.
Novo Nordisk, maker of weight-loss drug Wegovy, struck a deal with online telehealth storefronts that sold cheap knockoffs during shortages.
Suppliers are upset Temu is swapping to a more Amazon-esque supplier model and trying to drive prices ever-downward.
Vitol Group, the world’s largest independent oil trader, has paid around a record $6.4 billion in share buybacks to its employee-owners.
McDonald’s warned that customers might be getting sick of price hikes. It was right. Sales fell year-over-year for the first time since 2020.
Reducing beverage-wait times is part of Starbucks CEO Brian Niccol’s turnaround plan, which includes tech updates focused on efficiency.
Pioneering online education company 2U filed for bankruptcy, even as the public writ large has gradually embraced online learning.
Taylor Swift may be signed to the label, but Universal Music Group somehow can’t find a way to make its business work.
A patent for generative neural network-based ultrasounds from medical device firm Philips could provide more data to develop AI innovations throughout…
To prepare for a slowdown of global trade, US retailers spent months building a massive inventory to prevent empty shelves.
Hertz’s recent track record leaves much to be desired: the rental-car company lost nearly $2.9 billion last year.
Investor worries about a fresh batch of US tariffs have dragged LVMH shares in Paris down 23.6% so far this year.
The company plans to seek regulatory approval for the revolutionary weight loss treatment by the end of the year.